CRISPR Therapeutics AG (CRSP)
About CRISPR Therapeutics AG
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $3.5M
- Net income
- -$581.6M
- Total assets
- $2.3B
- Market cap
- $4.6B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $4.6B
- Shares outstanding
- 93.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 19, 2016
CRISPR Therapeutics AG (CRSP) Stock Price
- Reported a net loss of $581.6M in FY2025.
- Trading 36% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CRISPR Therapeutics AG.
Write a review
News about CRISPR Therapeutics AG
News & sentiment via Polygon.io
CRISPR Therapeutics AG: frequently asked questions
Is CRISPR Therapeutics AG an American company?
No — CRISPR Therapeutics AG is not an American company. CRISPR Therapeutics AG is incorporated in Switzerland. It maintains US operations and its shares trade on NASDAQ — which is why it is often mistaken for a US company.
Where is CRISPR Therapeutics AG incorporated?
CRISPR Therapeutics AG is legally incorporated in Switzerland, according to its GLEIF legal-entity record.
Is CRISPR Therapeutics AG traded on a US stock exchange?
Yes — CRISPR Therapeutics AG trades under the ticker CRSP on the NASDAQ. A US stock listing does not by itself make a company American — incorporation and ownership are what this page reports.
Is CRISPR Therapeutics AG publicly traded?
Yes — CRISPR Therapeutics AG is a publicly traded company. Its stock trades under the ticker symbol CRSP on the NASDAQ.
What does CRISPR Therapeutics AG do?
CRISPR Therapeutics AG is an American Pharmaceuticals company in the Health & Beauty sector.
